Cure Sickle Cell Initiative Clinical Trial Stage Projects

Return to Grants

---

Awards

Institution	Investigator	Grant Title	Award Value
Boston Children’s Hospital	David Williams	Phase 2 Study of Hematopoietic Stem Cell Gene Transfer Inducing Fetal Hemoglobin in Sickle Cell Disease	$8,333,581
University of California, San Francisco	Mark C. Walters M.D.	Transplantation of CRISPR-CAS9 Corrected Hematopoietic Stem Cells (CRISPR_SCD001) in Patients with Severe Sickle Cell Disease	$8,389,407
ExCellThera Inc.	Dr Pierre Caudrelier	A Phase 1 Study of ECT-001 Expanded Cord Blood and Myeloablative Regimen with Reduced Toxicity in Patients with Severe Sickle Cell Disease.	$600,000
			Total: $17,322,988.00